{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:40:55Z","timestamp":1790959255415,"version":"4.1.0"},"publisher-location":"New York, NY","reference-count":36,"publisher":"Springer US","isbn-type":[{"value":"9781071641873","type":"print"},{"value":"9781071641880","type":"electronic"}],"license":[{"start":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T00:00:00Z","timestamp":1729296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T00:00:00Z","timestamp":1729296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4188-0_19","type":"book-chapter","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T18:03:07Z","timestamp":1729274587000},"page":"429-448","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Establishing Patient-Derived Xenograft (PDX) Models of Lymphomas"],"prefix":"10.1007","author":[{"given":"Christopher","family":"Steel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily R.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie D.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne D.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,19]]},"reference":[{"key":"19_CR1","doi-asserted-by":"publisher","first-page":"8976","DOI":"10.1002\/cam4.4394","volume":"10","author":"T Nishimori","year":"2021","unstructured":"Nishimori T, Higuchi T, Hashida Y et al (2021) Development of a novel cell line-derived xenograft model of primary herpesvirus 8-unrelated effusion large B-cell lymphoma and antitumor activity of birabresib in vitro and in vivo. Cancer Med 10:8976\u20138987","journal-title":"Cancer Med"},{"key":"19_CR2","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1158\/0008-5472.CAN-13-2971","volume":"74","author":"JL Wilding","year":"2014","unstructured":"Wilding JL, Bodmer WF (2014) Cancer cell lines for drug discovery and development. Cancer Res 74:2377\u20132384","journal-title":"Cancer Res"},{"key":"19_CR3","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.5981","volume":"6","author":"AT Collins","year":"2018","unstructured":"Collins AT, Lang SH (2018) A systematic review of the validity of patient derived xenograft (PDX) models: the implications for translational research and personalised medicine. PeerJ 6:e5981","journal-title":"PeerJ"},{"key":"19_CR4","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/s41375-018-0043-y","volume":"32","author":"S Araf","year":"2018","unstructured":"Araf S, Wang J, Korfi K et al (2018) Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma. Leukemia 32:1258\u20131263","journal-title":"Leukemia"},{"key":"19_CR5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40164-015-0019-9","volume":"4","author":"E Derenzini","year":"2015","unstructured":"Derenzini E, Iacobucci I, Agostinelli C et al (2015) Therapeutic implications of intratumor heterogeneity for TP53 mutational status in Burkitt lymphoma. Exp Hematol Oncol 4:24","journal-title":"Exp Hematol Oncol"},{"key":"19_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00109-020-01874-2","volume":"98","author":"S Ram\u00f3n y Cajal","year":"2020","unstructured":"Ram\u00f3n y Cajal S, Ses\u00e9 M, Capdevila C et al (2020) Clinical implications of intratumor heterogeneity: challenges and opportunities. J Mol Med 98:161\u2013177","journal-title":"J Mol Med"},{"key":"19_CR7","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1182\/blood-2015-09-672352","volume":"127","author":"B Chapuy","year":"2016","unstructured":"Chapuy B, Cheng H, Watahiki A et al (2016) Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease. Blood 127:2203\u20132213","journal-title":"Blood"},{"key":"19_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-022-01259-6","volume":"8","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wu W, Cai C et al (2023) Patient-derived xenograft models in cancer therapy: technologies and applications. Signal Transduct Target Ther 8:1\u201324","journal-title":"Signal Transduct Target Ther"},{"key":"19_CR9","doi-asserted-by":"publisher","first-page":"1098581","DOI":"10.3389\/fonc.2023.1098581","volume":"13","author":"W Liu","year":"2023","unstructured":"Liu W, Cui Y, Zheng X et al (2023) Application status and future prospects of the PDX model in lung cancer. Front Oncol 13:1098581","journal-title":"Front Oncol"},{"key":"19_CR10","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/nm.3954","volume":"21","author":"H Gao","year":"2015","unstructured":"Gao H, Korn JM, Ferretti S et al (2015) High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response. Nat Med 21:1318\u20131325","journal-title":"Nat Med"},{"key":"19_CR11","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4049\/jimmunol.154.1.180","volume":"154","author":"LD Shultz","year":"1995","unstructured":"Shultz LD, Schweitzer PA, Christianson SW et al (1995) Multiple defects in innate and adaptive immunologic function in NOD\/LtSz-scid mice. J Immunol 154:180\u2013191","journal-title":"J Immunol"},{"key":"19_CR12","first-page":"149","volume":"7","author":"M Pelleitier","year":"1975","unstructured":"Pelleitier M, Montplaisir S (1975) The nude mouse: a model of deficient T-cell function. Methods Achiev Exp Pathol 7:149\u2013166","journal-title":"Methods Achiev Exp Pathol"},{"key":"19_CR13","doi-asserted-by":"publisher","first-page":"1007579","DOI":"10.3389\/fimmu.2022.1007579","volume":"13","author":"J Chen","year":"2022","unstructured":"Chen J, Liao S, Xiao Z et al (2022) The development and improvement of immunodeficient mice and humanized immune system mouse models. Front Immunol 13:1007579","journal-title":"Front Immunol"},{"key":"19_CR14","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/sj.bjc.6605642","volume":"102","author":"P Workman","year":"2010","unstructured":"Workman P, Aboagye EO, Balkwill F et al (2010) Guidelines for the welfare and use of animals in cancer research. Br J Cancer 102:1555\u20131577","journal-title":"Br J Cancer"},{"key":"19_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4143\/crt.2017.307","volume":"50","author":"J Jung","year":"2018","unstructured":"Jung J, Seol HS, Chang S (2018) The generation and application of patient-derived xenograft model for cancer research. Cancer Res Treat 50:1\u201310","journal-title":"Cancer Res Treat"},{"key":"19_CR16","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.neo.2015.09.004","volume":"17","author":"G Bondarenko","year":"2015","unstructured":"Bondarenko G, Ugolkov A, Rohan S et al (2015) Patient-derived tumor xenografts are susceptible to formation of human lymphocytic tumors. Neoplasia 17:735\u2013741","journal-title":"Neoplasia"},{"key":"19_CR17","doi-asserted-by":"publisher","first-page":"50150","DOI":"10.18632\/oncotarget.10322","volume":"7","author":"J Mukohyama","year":"2016","unstructured":"Mukohyama J, Iwakiri D, Zen Y et al (2016) Evaluation of the risk of lymphomagenesis in xenografts by the PCR-based detection of EBV BamHI W region in patient cancer specimens. Oncotarget 7:50150\u201350160","journal-title":"Oncotarget"},{"key":"19_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039294","volume":"7","author":"K Chen","year":"2012","unstructured":"Chen K, Ahmed S, Adeyi O et al (2012) Human solid tumor xenografts in immunodeficient mice are vulnerable to lymphomagenesis associated with Epstein-Barr virus. PLoS One 7:e39294","journal-title":"PLoS One"},{"key":"19_CR19","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1097\/JTO.0b013e3182519d4d","volume":"7","author":"T John","year":"2012","unstructured":"John T, Yanagawa N, Kohler D et al (2012) Characterization of lymphomas developing in immunodeficient mice implanted with primary human non-small cell lung cancer. J Thorac Oncol 7:1101\u20131108","journal-title":"J Thorac Oncol"},{"key":"19_CR20","doi-asserted-by":"publisher","first-page":"1156743","DOI":"10.3389\/fonc.2023.1156743","volume":"13","author":"DR Pearce","year":"2023","unstructured":"Pearce DR, Akarca AU, De Maeyer RPH et al (2023) Phenotyping of lymphoproliferative tumours generated in xenografts of non-small cell lung cancer. Front Oncol 13:1156743","journal-title":"Front Oncol"},{"key":"19_CR21","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.18632\/oncotarget.27001","volume":"10","author":"AM Moyer","year":"2019","unstructured":"Moyer AM, Yu J, Sinnwell JP et al (2019) Spontaneous murine tumors in the development of patient-derived xenografts: a potential pitfall. Oncotarget 10:3924\u20133930","journal-title":"Oncotarget"},{"key":"19_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101133","volume":"14","author":"S Chateau-Joubert","year":"2021","unstructured":"Chateau-Joubert S, Hopfe M, Richon S et al (2021) Spontaneous mouse lymphoma in patient-derived tumor xenografts: the importance of systematic analysis of xenografted human tumor tissues in preclinical efficacy trials. Transl Oncol 14:101133","journal-title":"Transl Oncol"},{"key":"19_CR23","first-page":"5828","volume":"62","author":"PPL Chiu","year":"2002","unstructured":"Chiu PPL, Ivakine E, Mortin-Toth S, Danska JS (2002) Susceptibility to lymphoid neoplasia in immunodeficient strains of nonobese diabetic mice. Cancer Res 62:5828\u20135834","journal-title":"Cancer Res"},{"key":"19_CR24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/0300985819882631","volume":"57","author":"H Tillman","year":"2020","unstructured":"Tillman H, Janke LJ, Funk A et al (2020) Morphologic and immunohistochemical characterization of spontaneous lymphoma\/leukemia in NSG mice. Vet Pathol 57:160\u2013171","journal-title":"Vet Pathol"},{"key":"19_CR25","first-page":"227","volume":"61","author":"P Huang","year":"2011","unstructured":"Huang P, Westmoreland SV, Jain RK, Fukumura D (2011) Spontaneous nonthymic tumors in SCID mice. Comp Med 61:227\u2013234","journal-title":"Comp Med"},{"key":"19_CR26","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1158\/0008-5472.CAN-17-0582","volume":"77","author":"TF Meehan","year":"2017","unstructured":"Meehan TF, Conte N, Goldstein T et al (2017) PDX-MI: minimal information for patient-derived tumor xenograft models. Cancer Res 77:e62\u2013e66","journal-title":"Cancer Res"},{"key":"19_CR27","doi-asserted-by":"publisher","first-page":"4754","DOI":"10.1182\/blood.V87.11.4754.bloodjournal87114754","volume":"87","author":"HJ Sutherland","year":"1996","unstructured":"Sutherland HJ, Blair A, Zapf RW (1996) Characterization of a hierarchy in human acute myeloid leukemia progenitor cells. Blood 87:4754\u20134761","journal-title":"Blood"},{"key":"19_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41523-022-00502-1","volume":"9","author":"GV Echeverria","year":"2023","unstructured":"Echeverria GV, Cai S, Tu Y et al (2023) Predictors of success in establishing orthotopic patient-derived xenograft models of triple negative breast cancer. NPJ Breast Cancer 9:1\u20139","journal-title":"NPJ Breast Cancer"},{"key":"19_CR29","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12967-022-03405-8","volume":"20","author":"S Abdolahi","year":"2022","unstructured":"Abdolahi S, Ghazvinian Z, Muhammadnejad S et al (2022) Patient-derived xenograft (PDX) models, applications and challenges in cancer research. J Transl Med 20:206","journal-title":"J Transl Med"},{"key":"19_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098856","volume":"9","author":"JA Hirst","year":"2014","unstructured":"Hirst JA, Howick J, Aronson JK et al (2014) The need for randomization in animal trials: an overview of systematic reviews. PLoS One 9:e98856","journal-title":"PLoS One"},{"key":"19_CR31","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.10681","volume":"9","author":"J Dickinson","year":"2021","unstructured":"Dickinson J, de Matas M, Dickinson PA, Mistry HB (2021) Exploring a model-based analysis of patient derived xenograft studies in oncology drug development. PeerJ 9:e10681","journal-title":"PeerJ"},{"key":"19_CR32","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/ilar\/ilu034","volume":"55","author":"DL Pearl","year":"2014","unstructured":"Pearl DL (2014) Making the most of clustered data in laboratory animal research using multi-level models. ILAR J 55:486\u2013492","journal-title":"ILAR J"},{"key":"19_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.18383\/j.tom.2016.00100","volume":"2","author":"JP Miller","year":"2016","unstructured":"Miller JP, Egbulefu C, Prior JL et al (2016) Gradient-based algorithm for determining tumor volumes in small animals using planar fluorescence imaging platform. Tomography 2:17\u201325","journal-title":"Tomography"},{"key":"19_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000411","volume":"18","author":"NP du Sert","year":"2020","unstructured":"du Sert NP, Ahluwalia A, Alam S et al (2020) Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol 18:e3000411","journal-title":"PLoS Biol"},{"key":"19_CR35","doi-asserted-by":"publisher","first-page":"891","DOI":"10.7863\/jum.2010.29.6.891","volume":"29","author":"GD Ayers","year":"2010","unstructured":"Ayers GD, McKinley ET, Zhao P et al (2010) Volume of preclinical xenograft tumors is more accurately assessed by ultrasound imaging than manual caliper measurements. J Ultrasound Med 29:891\u2013901","journal-title":"J Ultrasound Med"},{"key":"19_CR36","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3390\/ph15060747","volume":"15","author":"F Krutzek","year":"2022","unstructured":"Krutzek F, Kopka K, Stadlbauer S (2022) Development of radiotracers for imaging of the PD-1\/PD-L1 Axis. Pharmaceuticals 15:747","journal-title":"Pharmaceuticals"}],"container-title":["Methods in Molecular Biology","Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4188-0_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T18:06:03Z","timestamp":1729274763000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4188-0_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,19]]},"ISBN":["9781071641873","9781071641880"],"references-count":36,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4188-0_19","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,19]]},"assertion":[{"value":"19 October 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}